Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

723 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bioresorbable vascular scaffolds: Time to absorb past lessons or fade away?
de Pommereau A, de Hemptinne Q, Varenne O, Picard F. de Pommereau A, et al. Among authors: picard f. Arch Cardiovasc Dis. 2018 Apr;111(4):229-232. doi: 10.1016/j.acvd.2018.04.001. Epub 2018 Apr 17. Arch Cardiovasc Dis. 2018. PMID: 29678390 Free article. No abstract available.
Vasospastic angina: A literature review of current evidence.
Picard F, Sayah N, Spagnoli V, Adjedj J, Varenne O. Picard F, et al. Arch Cardiovasc Dis. 2019 Jan;112(1):44-55. doi: 10.1016/j.acvd.2018.08.002. Epub 2018 Sep 7. Arch Cardiovasc Dis. 2019. PMID: 30197243 Free article. Review.
Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
Falissard B, Picard F, Mahe I, Hanon O, Touzé E, Danchin N, Lamy FX, Ricci L, Steg PG. Falissard B, et al. Among authors: picard f. Arch Cardiovasc Dis. 2019 Jun-Jul;112(6-7):400-409. doi: 10.1016/j.acvd.2019.02.003. Epub 2019 Apr 20. Arch Cardiovasc Dis. 2019. PMID: 31014991 Free article.
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non-valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study.
Picard F, Van Ganse E, Ducrocq G, Danchin N, Falissard B, Hanon O, Belhassen M, Ginoux M, Lefevre C, Cotte FE, Mahé I, Steg PG. Picard F, et al. Clin Cardiol. 2019 Oct;42(10):851-859. doi: 10.1002/clc.23231. Epub 2019 Jul 17. Clin Cardiol. 2019. PMID: 31313832 Free PMC article.
723 results